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Introduction
Fluoroquinolone (FQ) resistance in Mycobacterium
tuberculosis can be conferred by mutations in gyrA or
gyrB gene. Recent studies suggest that amino acid sub-
stitutions in gyrB gene may also play a crucial role in
resistance, but genetic studies of these mutations in M.
tuberculosis are lacking.
Methods
A total of 100 ofloxacin resistant (OFX r) and 100 OFX
sensitive (OFX s) isolates of M.tuberculosis isolates were
consecutively selected from routine TB laboratory dur-
ing 2012-2013. All the isolates were screened for pheno-
typic OFX r (>2µg/ml) by 1% proportion method and
tested for minimal inhibitory concentration by absolute
concentration method. Quinolone resistance determin-
ing region (QRDR) of gyrA and gyrB genes of 320bp and
428bp respectively were amplified, sequenced and com-
pared with M.tuberculosis H37Rv.
Results
Mutations in the gyrB gene were observed in 5 of the 100
OFX r isolates. The single nucleotide mutation sites were
in codons 538, 500, 539 (in two isolates) and 592. In one
isolate, a substitution at codon 592 (Pro592Ser) was
found as novel mutation outside QRDR region of gyrB
gene. Accession nos. of these isolates include; KF509920-
KF509922, KC880086 & KC880101. All the isolates
showing mutations in gyrB gene also had mutations in
gyrA gene. Mutations in gyrA gene were observed in 79%
OFX r isolates. No mutation was observed in gyrB gene
of OFX s isolates.
Conclusion
No OFX r isolates had shown mutation in the gyrB gene
in the absence of gyrA gene mutation. The role of the
gyrB gene mutation in conferring resistance to OFX in
M.tuberculosis needs to be studied further.
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